MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

被引：0
|
作者：
Gonzalez-Astorga, B. [1 ]
Luque, R. [1 ]
Castellon, V. [1 ]
Gonzalez, E. [1 ]
Sanchez, C. [1 ]
Soberino, J. [1 ]
Gonzalez, C. [1 ]
Ruiz, J. [1 ]
Zurita, M. [1 ]
Delgado, J. R. [1 ]
机构：
[1] Hosp Univ Virgen de las Nieves, Granada, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3366
引用
收藏
页码：S794 / S794
页数：1
相关论文
共 50 条
  • [1] MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
    Consolación Melguizo
    Jose Prados
    Beatriz González
    Raul Ortiz
    Angel Concha
    Pablo Juan Alvarez
    Roberto Madeddu
    Gloria Perazzoli
    Jaime Antonio Oliver
    Rodrigo López
    Fernando Rodríguez-Serrano
    Antonia Aránega
    [J]. Journal of Translational Medicine, 10
  • [2] MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
    Melguizo, Consolacion
    Prados, Jose
    Gonzalez, Beatriz
    Ortiz, Raul
    Concha, Angel
    Juan Alvarez, Pablo
    Madeddu, Roberto
    Perazzoli, Gloria
    Antonio Oliver, Jaime
    Lopez, Rodrigo
    Rodriguez-Serrano, Fernando
    Aranega, Antonia
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [3] Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
    Jaime Antonio Oliver
    Raúl Ortiz
    Consolación Melguizo
    Pablo Juan Álvarez
    Jaime Gómez-Millán
    Jose Prados
    [J]. BMC Cancer, 14
  • [4] Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
    Antonio Oliver, Jaime
    Ortiz, Raul
    Melguizo, Consolacion
    Juan Alvarez, Pablo
    Gomez-Millan, Jaime
    Prados, Jose
    [J]. BMC CANCER, 2014, 14
  • [5] Temozolomide Concomitant and Adjuvant to Radiotherapy in Elderly Patients With Glioblastoma Correlation With MGMT Promoter Methylation Status
    Brandes, Alba A.
    Franceschi, Enrico
    Tosoni, Alicia
    Benevento, Francesca
    Scopece, Luciano
    Mazzocchi, Valeria
    Bacci, Antonella
    Agati, Raffaele
    Calbucci, Fabio
    Ermani, Mario
    [J]. CANCER, 2009, 115 (15) : 3512 - 3518
  • [6] MGMT PROMOTER METHYLATION STATUS AND miRNA-181 FAMILY EXPRESSION AS PROGNOSTIC MARKERS IN GLIOBLASTOMA PATIENTS
    Bie, Li
    Hua, Cong
    Zhao, Gang
    Li, Yuanqian
    [J]. NEURO-ONCOLOGY, 2015, 17 : 10 - 10
  • [7] MGMT immunohistochemical expression and promoter methylation in human glioblastoma
    Rodriguez, Fausto J.
    Thibodeau, Stephen N.
    Jenkins, Robert B.
    Schowalter, Karen V.
    Caron, Bolette L.
    O'Neill, Brian P.
    James, Charles David
    Passe, Sandra
    Slezak, Jeff
    Giannini, Caterina
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2008, 16 (01): : 59 - 65
  • [8] MGMT Gene Promoter Methylation Status as a Potent Prognostic Factor in Glioblastoma Treated with Temozolomide Chemo-irradiation
    Kim, Y.
    Kim, S.
    Kim, J.
    Cho, J.
    Chang, J.
    Kim, D.
    Lee, K.
    Suh, C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S275 - S275
  • [9] MGMT promoter methylation status and expression in human glioblastoma
    Rodriguez, FJ
    Thibodeau, SN
    Jenkins, RB
    Schowalter, KV
    O'Neill, BP
    James, CD
    Giannini, C
    [J]. MODERN PATHOLOGY, 2006, 19 : 287A - 287A
  • [10] PROGNOSTIC AND PREDICTIVE SIGNIFICANCE Of MGMT PROMOTER METHYLATION AND PROTEIN EXPRESSION IN GLIOBLASTOMA PATIENTS
    Spiegl-Kreinecker, S.
    Pirker, C.
    Filipits, M.
    Loetsch, D.
    Buchroithner, J.
    Pichler, J.
    Silye, R.
    Micksche, M.
    Fischer, J.
    Berger, W.
    [J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1080 - 1080
12345